BMRA

Biomerica, Inc. NASDAQ Listed Sep 7, 1984

Healthcare ·Medical - Devices ·US · biomerica.com

$2.20

Mkt Cap $6.8M

52w Low $1.87 12.1% of range 52w High $4.60

50d MA $2.12 200d MA $2.58

P/E (TTM) -1.0x

EV/EBITDA -1.1x

P/B 1.2x

Debt/Equity 0.1x

ROE -154.4%

P/FCF -1.8x

RSI (14) —

ATR (14) —

Beta 0.20

50d MA $2.12

200d MA $2.58

Avg Volume 20.8K

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

SIC Code

2835

CIK (SEC)

73290

Phone

949 645 2111

17571 Von Karman Avenue · Irvine, CA 92614 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 13, 2026	AMC	-1.20	-0.44	+63.3%	2.08	-2.4%	+1.0%	+1.4%	+5.8%	+4.8%	+4.8%	—
Jan 14, 2026	AMC	—	-0.45	—	2.70	-1.9%	-0.7%	-4.8%	-5.2%	-8.5%	-4.8%	—
Oct 14, 2025	AMC	—	0.00	—	2.88	-1.4%	-0.7%	+4.5%	+3.5%	+8.3%	+11.1%	—
Apr 14, 2025	AMC	—	-0.48	—	4.42	+10.4%	+3.2%	-24.0%	-13.1%	-16.7%	-24.2%	—
Jan 14, 2025	AMC	—	-0.06	—	2.62	-2.3%	+6.9%	+115.6%	+95.4%	+83.2%	+90.8%	—
Oct 15, 2024	AMC	—	-0.08	—	2.57	+0.0%	+8.9%	+5.4%	+0.0%	+1.2%	+0.4%	—
Apr 12, 2024	AMC	—	-0.11	—	6.62	-0.9%	-6.9%	-10.7%	-9.2%	-8.2%	-11.8%	—
Jan 16, 2024	AMC	—	-0.09	—	7.65	+3.5%	-0.1%	-4.8%	-4.8%	-4.8%	+1.4%	—
Oct 12, 2023	AMC	—	-0.07	—	6.00	-4.0%	-1.2%	-4.0%	-1.2%	+2.7%	+4.3%	—
Aug 25, 2023	AMC	0.04	-0.10	-350.0%	9.20	+0.0%	+4.3%	+8.7%	+8.7%	+11.3%	+12.2%	—
Apr 14, 2023	AMC	0.02	-0.12	-700.0%	13.44	-1.2%	+3.0%	-1.8%	+0.0%	-0.6%	+3.0%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 5	Citizens	Initiates	Mkt Outperform	$9	$2.16	$2.17	+0.5%	+1.4%	+2.3%	+1.4%	—	—
Oct 19	Aegis Capital	Maintains	Buy → Buy	—	$46.72	$46.96	+0.5%	-3.4%	-4.1%	-5.7%	-3.1%	-3.9%
Sep 4	Aegis Capital	Maintains	Buy → Buy	—	$46.88	$47.36	+1.0%	+17.6%	+10.1%	+15.9%	+15.5%	+13.1%
Aug 21	Aegis Capital	Maintains	Buy → Buy	—	$62.32	$62.32	+0.0%	-0.9%	-5.5%	-5.3%	-1.9%	-4.1%
Dec 17	B. Riley FBR	Maintains	Buy → Buy	—	$20.80	$19.52	-6.2%	-5.0%	-6.5%	-8.1%	-13.5%	-22.3%
Dec 17	B. Riley Securities	Maintains	Buy → Buy	—	$20.80	$19.52	-6.2%	-5.0%	-6.5%	-8.1%	-13.5%	-22.3%

Data updated apr 24, 2026 10:14pm · Source: massive.com